learn
Reading sex subgroup results
Why a significant p-value in one subgroup does not prove a sex difference.
A subgroup result in women becomes convincing only when the analysis was prespecified, the subgroup is large enough, and the treatment-by-sex interaction is reported with a confidence interval. A p-value inside one subgroup, by itself, is weak evidence of a true sex difference.
Key takeaways
- Prespecified subgroup analyses are more reliable than post-hoc ones.
- A treatment-by-sex interaction test asks whether the sexes respond differently, not whether each sex responds.
- Small subgroups produce wide confidence intervals and fragile p-values.
- Overlap of confidence intervals in a forest plot suggests the difference may be noise.
Subgroup analyses are everywhere in medical literature. A trial reports its main result, then breaks that result into smaller groups: men and women, older and younger adults, people with and without diabetes. It is tempting to treat each subgroup p-value as a separate finding, but that is usually a mistake.
The most important distinction is whether the subgroup analysis was prespecified. A prespecified analysis is written into the trial protocol and statistical plan before anyone sees the data. A post-hoc analysis is dreamed up after the data arrive. Post-hoc subgroup findings are useful for generating hypotheses, not for proving them.
When reading a sex subgroup result, look for a treatment-by-sex interaction test. This test asks a different question than "Did the drug work in women?" It asks, "Did the size of the drug effect differ between women and men?" If the interaction p-value is not significant, the trial does not provide convincing evidence that the drug acts differently by sex, even if the point estimate looks larger in one group.
Even a significant interaction must be interpreted with caution if the subgroup is small. A subgroup with a few hundred participants has a wide confidence interval. The observed difference may be real, but it may also be a chance fluctuation. Forest plots help: if the confidence intervals for women and men overlap substantially, the apparent difference is likely noise.
Finally, distinguish quantitative from qualitative interactions. A quantitative interaction means the drug works in both groups but the magnitude differs. A qualitative interaction means the drug appears helpful in one group and harmful or useless in the other. Qualitative interactions are much rarer and require stronger evidence. Most reported sex differences in peptide-medicine trials are quantitative, not qualitative.
In short, do not stop at the headline "Women lost more weight." Ask whether the comparison was planned, how large the subgroup was, what the interaction test showed, and whether the confidence intervals overlap.
Frequently asked questions
Sources
Primary records
- regulatory review
FDA statistical review including subgroup analyses by sex for SURMOUNT-1 and SURMOUNT-2.
Secondary context
- regulatory review
FDA resource summarizing demographic participation in drug trials.
Medical disclaimer: Her Health Peptides publishes educational, source-linked summaries. We do not provide individualized medical advice, diagnosis, or treatment recommendations. Always talk with a licensed clinician about your specific situation, especially if you are pregnant, breastfeeding, planning pregnancy, or taking other medicines.
Join the conversation
Comments are moderated. Please keep discussion focused on the evidence and avoid sharing personal health information.
Loading comments...